Cookie Img
Send SMS    Call Me Free
Home » Products » Anti-Cancer Products » Ramucinumab

Ramucinumab

Ramucinumab
Ramucinumab
Product Code : #0063
Brand Name : Cyramza
Product Specifications
  • Minimum Order Quantity
  • Formulations Type
  • Injectables
  • Formulations Form
  • Liquid
  • Gender/Age Group
  • Adult
Trade Information
  • Payment Terms
  • Cash on Delivery (COD), Cash Advance (CA), Delivery Point (DP), Western Union
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • Main Domestic Market
  • All India
Product Description

Ramucirumab[1] (IMC-1121B, trade name Cyramza[2][3]) is a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors. This drug was developed by ImClone Systems Inc. It was isolated from a native phage display library from Dyax.

 

Cyramza (ramucirumab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Cyramza is used to treat stomach cancer, colorectal cancer, or non-small cell lung cancer that has spread to other parts of the body. Ramucirumab may be given alone or in combination with other cancer medicines.

Cyramza is usually given after other cancer medicines have been tried without success.

 

 


AMBICA PHARMA

Contact Us

( *represents compulsory fields )

Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



AMBICA PHARMA All Rights Reserved.